An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays

Journal of Proteomics

Volumn 75, Issue 15, 2012, Pages 4647-4655

  Barderas, Rodrigo ^a   Babel, Ingrid ^a,g   Díaz Uriarte, Ramón ^b   Moreno, Víctor ^c,d   Suárez, Adolfo ^e   Bonilla, Felix ^f   Villar Vázquez, Roi ^a   Capellá, Gabriel ^c   Casal, J Ignacio ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL DE CABUEÑES   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^g Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Autoantibodies; Colorectal cancer; Diagnosis; Protein microarrays; Tumor associated antigens

Indexed keywords

AUTOANTIBODY; FIBROBLAST GROWTH FACTOR RECEPTOR 4; MACROPHAGE ACTIVATING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; PROTEIN KINASE PIM 1; PROTEIN TYROSINE KINASE; TUMOR ANTIGEN;

ANTIGEN BINDING; ARTICLE; BACTERIOPHAGE T7; CANCER DIAGNOSIS; CANCER STAGING; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PEPTIDE LIBRARY; PREDICTIVE VALUE OF TESTS;

EID: 84864113921     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.03.004     Document Type: Article

References (32)

1. Edwards B.K., Ward E., Kohler B.A., Eheman C., Zauber A.G., Anderson R.N., et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010, 116:544-573.
2. Duffy M.J., van Dalen A., Haglund C., Hansson L., Holinski-Feder E., Klapdor R., et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 2007, 43:1348-1360.
3. Locker G.Y., Hamilton S., Harris J., Jessup J.M., Kemeny N., Macdonald J.S., et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006, 24:5313-5327.
4. Orenes-Pinero E., Barderas R., Rico D., Casal J.I., Gonzalez-Pisano D., Navajo J., et al. Serum and tissue profiling in bladder cancer combining protein and tissue arrays. J Proteome Res 2010, 9:164-173.
5. Chapman C., Murray A., Chakrabarti J., Thorpe A., Woolston C., Sahin U., et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 2007, 18:868-873.
6. Chapman C.J., Murray A., McElveen J.E., Sahin U., Luxemburger U., Tureci O., et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008, 63:228-233.
7. Hudson M.E., Pozdnyakova I., Haines K., Mor G., Snyder M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci U S A 2007, 104:17494-17499.
8. Soussi T. p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res 2000, 60:1777-1788.
9. Chen G., Gharib T.G., Huang C.C., Thomas D.G., Shedden K.A., Taylor J.M., et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 2002, 8:2298-2305.
10. Chen Y., Lin P., Qiu S., Peng X.X., Looi K., Farquhar M.G., et al. Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. Int J Oncol 2007, 30:1137-1144.
11. Chen Y.T., Scanlan M.J., Sahin U., Tureci O., Gure A.O., Tsang S., et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A 1997, 94:1914-1918.
12. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000, 404:770-774.
13. Ulanet D.B., Torbenson M., Dang C.V., Casciola-Rosen L., Rosen A. Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci U S A 2003, 100:12361-12366.
14. von Mensdorff-Pouilly S., Petrakou E., Kenemans P., van Uffelen K., Verstraeten A.A., Snijdewint F.G., et al. Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. Int J Cancer 2000, 86:702-712.
15. Casal J.I., Barderas R. Identification of cancer autoantigens in serum: toward diagnostic/prognostic testing?. Mol Diagn Ther 2010, 14:149-154.
16. Anderson K.S., LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 2005, 4:1123-1133.
17. Adam J.K., Odhav B., Bhoola K.D. Immune responses in cancer. Pharmacol Ther 2003, 99:113-132.
18. Babel I., Barderas R., Diaz-Uriarte R., Martinez-Torrecuadrada J.L., Sanchez-Carbayo M., Casal J.I. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics 2009, 8:2382-2395.
19. Chatterjee M., Ionan A., Draghici S., Tainsky M.A. Epitomics: global profiling of immune response to disease using protein microarrays. Omics 2006, 10:499-506.
20. Sreekumar A., Laxman B., Rhodes D.R., Bhagavathula S., Harwood J., Giacherio D., et al. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. J Natl Cancer Inst 2004, 96:834-843.
21. Wang X., Yu J., Sreekumar A., Varambally S., Shen R., Giacherio D., et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005, 353:1224-1235.
22. Scanlan M.J., Chen Y.T., Williamson B., Gure A.O., Stockert E., Gordan J.D., et al. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998, 76:652-658.
23. Scanlan M.J., Welt S., Gordon C.M., Chen Y.T., Gure A.O., Stockert E., et al. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res 2002, 62:4041-4047.
24. Gnjatic S., Ritter E., Buchler M.W., Giese N.A., Brors B., Frei C., et al. Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci U S A 2010, 107:5088-5093.
25. Klade C.S., Voss T., Krystek E., Ahorn H., Zatloukal K., Pummer K., et al. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 2001, 1:890-898.
26. Anderson K.S., Ramachandran N., Wong J., Raphael J.V., Hainsworth E., Demirkan G., et al. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J Proteome Res 2008, 7:1490-1499.
27. Babel I., Barderas R., Diaz-Uriarte R., Moreno V., Suarez A., Fernandez-Aceñero M.J., et al. Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays. Mol Cell Proteomics 2011, 10. M110 001784.
28. Alfonso P., Nuñez A., Madoz-Gurpide J., Lombardia L., Sanchez L., Casal J.I. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005, 5:2602-2611.
29. Barderas R., Desmet J., Timmerman P., Meloen R., Casal J.I. Affinity maturation of antibodies assisted by in silico modeling. Proc Natl Acad Sci U S A 2008, 105:9029-9034.
30. R Core Development Team R: a Language and Environment for Statistical Computing 2009, The R Foundation for Statistical Computing, Vienna.
31. Harrell F.E. Regression Modeling Strategies 2001, Springer.
32. Venables W.N., Ripley B.D. Modern applied statistics with S 2001, Springer.